or Try an Advanced Search...

    Technical Analysis for NDRA - ENDRA Life Sciences Inc.

    Grade Last Price % Change Price Change
    D 0.28 10.93% 0.03
    NDRA closed up 10.93 percent on Friday, November 1, 2024, on 10 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: Nov 12
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Down Up Down
    Historical NDRA trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    Crossed Above 50 DMA Bullish 0.00%
    1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    NR7 Range Contraction 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Fell Below 50 DMA Bearish 10.93%
    Wide Bands Range Expansion 10.93%
    Older End-of-Day Signals for NDRA ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 1 day ago
    Fell Below 20 DMA 1 day ago
    20 DMA Support 1 day ago
    Down 3% 1 day ago
    Down 2 % 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    NDRA Chart by TradingView
    Basic chart:

    Profile

    ENDRA Life Sciences Inc. develops photo- and thermo-acoustic medical technologies that bring new capabilities to existing ultrasound systems. Its photo-acoustic solutions help global medical researchers to screen and modify disease models with high image quality and volume scanning speed. The company offers the Nexus-128 system, a fully 3D imaging solution for imaging anatomy, physiology, and labeled molecular targets for institutions. Its thermo-acoustic technology is being developed to enable clinicians to use their existing ultrasound equipment to visualize tissue function, composition, and monitor various therapeutic interventions at the point of care. The company was incorporated in 2007 and is headquartered in Ann Arbor, Michigan.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Medicine Disease Imaging Medical Equipment Applied Sciences Medical Imaging Medical Research Ultrasound Medical Physics Canning Physiology Medical Technologies 3d Imaging Medical Ultrasonography Medical Ultrasound

    Is NDRA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 2 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 22 Why ENDRA Life Sciences (NDRA) Stock Is Up 140%
    Oct 22 ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany
    Oct 3 Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
    Oct 2 EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
    Aug 30 Data I/O And 2 Other Stocks Under $5 Executives Are Buying
    Aug 28 ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements
    Aug 28 ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements
    Aug 22 ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript
    Aug 22 Endra Life Sciences GAAP EPS of -$0.08 misses by $0.01
    Aug 22 ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update
    See more NDRA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 138.5
    52 Week Low 0.1814
    Average Volume 12,305,658
    200-Day Moving Average 17.66
    50-Day Moving Average 0.27
    20-Day Moving Average 0.25
    10-Day Moving Average 0.29
    Average True Range 0.07
    RSI (14) 48.98
    ADX 53.3
    +DI 36.80
    -DI 13.58
    Chandelier Exit (Long, 3 ATRs) 0.44
    Chandelier Exit (Short, 3 ATRs) 0.39
    Upper Bollinger Bands 0.36
    Lower Bollinger Band 0.14
    Percent B (%b) 0.63
    BandWidth 88.05
    MACD Line -0.04
    MACD Signal Line -0.07
    MACD Histogram 0.0291
    Fundamentals Value
    Market Cap 2.36 Million
    Num Shares 8.45 Million
    EPS -2.56
    Price-to-Earnings (P/E) Ratio -0.11
    Price-to-Sales 0.00
    Price-to-Book 1.90
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.33
    Resistance 3 (R3) 0.33 0.30 0.32
    Resistance 2 (R2) 0.30 0.29 0.31 0.32
    Resistance 1 (R1) 0.29 0.28 0.30 0.30 0.32
    Pivot Point 0.27 0.27 0.27 0.27 0.27
    Support 1 (S1) 0.26 0.25 0.26 0.26 0.24
    Support 2 (S2) 0.23 0.24 0.23 0.24
    Support 3 (S3) 0.22 0.23 0.23
    Support 4 (S4) 0.23